Search by Drug Name or NDC
NDC 00023-6630-03 Refresh Relieva 5; 9 mg/mL; mg/mL Details
Refresh Relieva 5; 9 mg/mL; mg/mL
Refresh Relieva is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN.
Product Information
| NDC | 00023-6630 |
|---|---|
| Product ID | 0023-6630_0cdd2598-7802-4f90-ba37-d8eb75d8332b |
| Associated GPIs | 86209902122010 |
| GCN Sequence Number | 062806 |
| GCN Sequence Number Description | carboxymethylcellulos/glycerin DROPS 0.5%-0.9% OPHTHALMIC |
| HIC3 | Q6T |
| HIC3 Description | ARTIFICIAL TEARS |
| GCN | 98577 |
| HICL Sequence Number | 034858 |
| HICL Sequence Number Description | CARBOXYMETHYLCELLULOSE SODIUM/GLYCERIN |
| Brand/Generic | Brand |
| Proprietary Name | Refresh Relieva |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Carboxymethylcellulose sodium, Glycerin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 5; 9 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | CARBOXYMETHYLCELLULOSE SODIUM; GLYCERIN |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M018 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00023-6630-03 (00023663003)
| NDC Package Code | 0023-6630-03 |
|---|---|
| Billing NDC | 00023663003 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (0023-6630-03) / 3 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2019-07-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |